Ｍ－オンコリスバイオ（4588）　First Patient Dosed in NRG Oncology Phase I Clinical Trial for Telomelysin(OBP-301)-Chemoradiation Combination Therapy for Esophageal Cancer Patients 2021/12/07
/-
読み込み中…